header logo en

Trial Results

The following table lists the results of some of the many clinical trials available worldwide for kidney cancer patients. For more information about some of the ongoing trials, click here.

Note: The following lay summaries are provided for Patient Organizations to better understand the results of recent clinical trials. While these have been medically reviewed, please consult the cited Journals for full data.

 No.  Trial name Results  Agents  Phase  Status  Sponsor
 1 Checkmate 025 (for trial info please click here: Checkmate 025)
To view trial infographic click here: Infographic study results Checkmate 025
 
For a summary of the study results, read here: Study results summary
nivolumab versus everolimus
 III Stopped, results published Bristol-Myers Squibb
 2 Pembrolizumab + pazopanib (for trial info please click here: Pembrolizumab + pazopanib) For results please click here pembrolizumab + pazopanib  I still ongoing, preliminary results published Novartis
 3  METEOR
To view trial infographic click here: Infographic study results METEOR
 
For a summary of the study results, read here: Study results summary
cabozantinib + everolimus  III still ongoing but not recruiting  Exelixis
4 IMmotion150 For results please click here atezolizumab, bevacizumab, sunitinib II still ongoing but not recruiting Hoffmann-La Roche